KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Operating Leases (2020 - 2025)

Novavax has reported Operating Leases over the past 6 years, most recently at $21.4 million for Q4 2025.

  • Quarterly results put Operating Leases at $21.4 million for Q4 2025, down 72.03% from a year ago — trailing twelve months through Dec 2025 was $21.4 million (down 72.03% YoY), and the annual figure for FY2025 was $21.4 million, down 72.03%.
  • Operating Leases for Q4 2025 was $21.4 million at Novavax, down from $76.7 million in the prior quarter.
  • Over the last five years, Operating Leases for NVAX hit a ceiling of $84.5 million in Q4 2023 and a floor of $21.4 million in Q4 2025.
  • Median Operating Leases over the past 5 years was $76.7 million (2024), compared with a mean of $60.6 million.
  • Biggest five-year swings in Operating Leases: surged 107.9% in 2022 and later plummeted 72.03% in 2025.
  • Novavax's Operating Leases stood at $39.1 million in 2021, then surged by 107.9% to $81.3 million in 2022, then grew by 3.91% to $84.5 million in 2023, then dropped by 9.25% to $76.7 million in 2024, then plummeted by 72.03% to $21.4 million in 2025.
  • The last three reported values for Operating Leases were $21.4 million (Q4 2025), $76.7 million (Q4 2024), and $84.5 million (Q4 2023) per Business Quant data.